Regis Corporation short interest in 2023
In 2023, Regis Corporation's disclosed short interest ran from 7.53% of shares outstanding on 13 Jan 2023 to 2.30% on 15 Nov 2023, a change of -5.23 percentage points. The year's high was 7.53% on 13 Jan 2023 and its low 2.30% on 29 Sep 2023, averaging 4.02% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.26 days on 28 Feb 2023. Full history: Regis Corporation.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 7.53% (13 Jan 2023)
- End of year
- 2.30% (15 Nov 2023)
- Change
- -5.23 pp
- High
- 7.53% (13 Jan 2023)
- Low
- 2.30% (29 Sep 2023)
- Average
- 4.02%
- Highest days to cover
- 27.26 (28 Feb 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 7.53% | 9.38 | |
| 31 Jan 2023 | 6.52% | 9.35 | |
| 15 Feb 2023 | 6.33% | 10.04 | 10-Q filed, results (8-K) |
| 28 Feb 2023 | 6.30% | 27.26 | |
| 15 Mar 2023 | 6.99% | 7.99 | |
| 31 Mar 2023 | 4.98% | 2.95 | |
| 14 Apr 2023 | 4.79% | 26.86 | |
| 28 Apr 2023 | 4.76% | 13.90 | |
| 15 May 2023 | 3.75% | 8.45 | 10-Q filed, results (8-K) |
| 31 May 2023 | 3.44% | 14.02 | |
| 15 Jun 2023 | 3.31% | 10.02 | |
| 30 Jun 2023 | 3.39% | 10.99 | |
| 14 Jul 2023 | 2.90% | 14.42 | |
| 31 Jul 2023 | 2.79% | 9.10 | |
| 15 Aug 2023 | 2.59% | 16.38 | |
| 31 Aug 2023 | 2.49% | 8.43 | 10-K filed, results (8-K) |
| 15 Sep 2023 | 2.42% | 8.70 | |
| 29 Sep 2023 | 2.30% | 6.09 | |
| 13 Oct 2023 | 2.32% | 6.74 | |
| 31 Oct 2023 | 2.32% | 7.05 | |
| 15 Nov 2023 | 2.30% | 2.38 | 10-Q filed, results (8-K) |
See also: Regis Corporation's full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.